Headache: FDA reporting patterns
617,788 FDA FAERS reports mention Headache. 295,827 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 28,826 reports
- Etanercept: 24,443 reports
- Apremilast: 17,375 reports
- Treprostinil: 15,776 reports
- Methotrexate: 12,876 reports
- Infliximab: 12,705 reports
- Acetaminophen: 12,013 reports
- Tofacitinib: 11,627 reports
- Rituximab: 10,296 reports
- Natalizumab: 9,757 reports
- Human Immunoglobulin G: 9,717 reports
- Dupilumab: 9,121 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.